BE894185A - Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain - Google Patents

Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain

Info

Publication number
BE894185A
BE894185A BE6/47701A BE6047701A BE894185A BE 894185 A BE894185 A BE 894185A BE 6/47701 A BE6/47701 A BE 6/47701A BE 6047701 A BE6047701 A BE 6047701A BE 894185 A BE894185 A BE 894185A
Authority
BE
Belgium
Prior art keywords
human
peptide
pharmaceutical formulations
insulin
human insulin
Prior art date
Application number
BE6/47701A
Other languages
English (en)
Inventor
R E Chance
B H Frank
J A Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE894185A publication Critical patent/BE894185A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BE6/47701A 1981-08-27 1982-08-24 Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain BE894185A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
BE894185A true BE894185A (fr) 1983-02-24

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6/47701A BE894185A (fr) 1981-08-27 1982-08-24 Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain

Country Status (20)

Country Link
JP (1) JPS5846024A (fr)
AU (1) AU551879B2 (fr)
BE (1) BE894185A (fr)
CA (1) CA1176158A (fr)
CH (1) CH650679A5 (fr)
DE (1) DE3232034A1 (fr)
DZ (1) DZ452A1 (fr)
FR (1) FR2513126B1 (fr)
GB (1) GB2104382B (fr)
IE (1) IE54119B1 (fr)
IL (1) IL66611A0 (fr)
IT (1) IT1153182B (fr)
LU (1) LU84359A1 (fr)
MW (1) MW3882A1 (fr)
NL (1) NL192192C (fr)
NZ (1) NZ201682A (fr)
PH (1) PH19361A (fr)
SE (1) SE460334B (fr)
ZA (1) ZA826159B (fr)
ZW (1) ZW17482A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
CA1296253C (fr) * 1986-10-20 1992-02-25 Praveen Tyle Compositions d'hormones de croissance stabilisees
AU8175387A (en) * 1986-10-20 1988-05-06 Novo Industri A/S Protamine zinc insulin preparations
IE62879B1 (en) * 1987-02-25 1995-03-08 Novo Nordisk As Novel insulin derivatives
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
EP0303308B1 (fr) * 1987-08-14 1991-05-29 Akzo N.V. Préparation pour prévenir ou combattre des complications dans le diabète
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
CN101060856B (zh) * 2004-11-22 2011-01-19 诺和诺德公司 可溶、稳定的含胰岛素制剂
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
WO2010033207A1 (fr) 2008-09-19 2010-03-25 Nektar Therapeutics Conjugués polymères de peptides thérapeutiques
KR20130115086A (ko) * 2010-05-17 2013-10-21 세빅스 인코포레이티드 페길화된 c-펩티드
CN104220086A (zh) 2011-11-17 2014-12-17 塞比克斯股份公司 Peg化的c-肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
NL192192C (nl) 1997-03-04
GB2104382B (en) 1984-12-19
ZA826159B (en) 1984-04-25
NL192192B (nl) 1996-11-01
AU551879B2 (en) 1986-05-15
DE3232034C2 (fr) 1991-04-11
IT1153182B (it) 1987-01-14
IL66611A0 (en) 1982-12-31
AU8759482A (en) 1983-03-03
NZ201682A (en) 1985-08-16
SE460334B (sv) 1989-10-02
SE8204873D0 (sv) 1982-08-25
JPS5846024A (ja) 1983-03-17
DZ452A1 (fr) 2004-09-13
MW3882A1 (en) 1984-07-11
FR2513126B1 (fr) 1986-04-18
GB2104382A (en) 1983-03-09
IE822064L (en) 1983-02-27
IE54119B1 (en) 1989-06-21
IT8223017A0 (it) 1982-08-27
DE3232034A1 (de) 1983-03-10
CH650679A5 (de) 1985-08-15
NL8203315A (nl) 1983-03-16
PH19361A (en) 1986-04-02
FR2513126A1 (fr) 1983-03-25
ZW17482A1 (en) 1982-11-17
CA1176158A (fr) 1984-10-16
LU84359A1 (fr) 1983-02-28
SE8204873L (sv) 1983-02-28

Similar Documents

Publication Publication Date Title
PT78732B (de) 13-alpha-alkylgonane deren herstellung und diese enthaltende pharmazeutische praeparate
FR2513126B1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain
BE894188A (fr) Formulations pharmaceutiques comprenant de l'insuline et de la pro-insuline humaine
IT8324035A0 (it) Cefem composti ad attivita'farmaceutica e procedimenti per laloro preparazione.
GB2106115B (en) Pharmaceutical amides, and preparation, formulations and use thereof
BE894187A (fr) Formulations pharmaceutiques comprenant de l'insuline humaine un c- peptide humain et de la pro-insuline humaine
FR2511866B1 (fr) Formulations pharmaceutiques de pro-insuline humaine
IT1165553B (it) Composizione farmaceutica con attivita' antiaterosclerotica e procedimento per la sua preparazione
IT8420759A1 (it) Composizione ad attivita' farmaceutica perfezionata e sua utilizzazione per usi veterinari
IT1157306B (it) Vaccino contro le brucellosi umane e procedimento per la sua preparazione
ZA827001B (en) Pharmaceutical amides,and preparation,formulations and use thereof
BE885510A (fr) Medicament omni-potent dans la therapeutique contre la sclerose en plaque et l'arterio-sclerose
JO1236B1 (en) Pharmacy formulations that include human insulin and a human-c-peptide

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ELI LILLY AND CY

Effective date: 20020824